Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Heart Failure

  Free Subscription


Articles published in J Mol Cell Cardiol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    April 2019
  1. ALEXANIAN M, Padmanabhan A, McKinsey TA, Haldar SM, et al
    Epigenetic therapies in heart failure.
    J Mol Cell Cardiol. 2019 Apr 13. pii: S0022-2828(19)30063.
    PubMed     Text format     Abstract available


    March 2019
  2. AHMAD F, Singh AP, Tomar D, Rahmani M, et al
    Cardiomyocyte-GSK-3alpha promotes mPTP opening and heart failure in mice with chronic pressure overload.
    J Mol Cell Cardiol. 2019;130:65-75.
    PubMed     Text format     Abstract available


    February 2019
  3. OH JG, Jang SP, Yoo J, Lee MA, et al
    Role of the PRC2-Six1-miR-25 signaling axis in heart failure.
    J Mol Cell Cardiol. 2019 Feb 13. pii: S0022-2828(18)30916.
    PubMed     Text format     Abstract available


    November 2018
  4. WOULFE KC, Bruns DR
    From pediatrics to geriatrics: Mechanisms of heart failure across the life-course.
    J Mol Cell Cardiol. 2018 Nov 17. pii: S0022-2828(18)30960.
    PubMed     Text format     Abstract available


  5. BOECKEL JN, Perret MF, Glaser SF, Seeger T, et al
    Identification and regulation of the long non-coding RNA Heat2 in heart failure.
    J Mol Cell Cardiol. 2018;126:13-22.
    PubMed     Text format     Abstract available


    October 2018
  6. MATSUMURA N, Takahara S, Maayah ZH, Parajuli N, et al
    Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites.
    J Mol Cell Cardiol. 2018 Oct 28. pii: S0022-2828(18)30720.
    PubMed     Text format     Abstract available


    August 2018
  7. REDDY SS, Agarwal H, Barthwal MK
    Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice.
    J Mol Cell Cardiol. 2018 Aug 20. pii: S0022-2828(18)30815.
    PubMed     Text format     Abstract available


  8. PAPPAS CT, Farman GP, Mayfield RM, Konhilas JP, et al
    Cardiac-specific knockout of Lmod2 results in a severe reduction in myofilament force production and rapid cardiac failure.
    J Mol Cell Cardiol. 2018 Aug 10. pii: S0022-2828(18)30789.
    PubMed     Text format     Abstract available


  9. HUANG CY, Lai CH, Kuo CH, Chiang SF, et al
    Inhibition of ERK-Drp1 signaling and mitochondria fragmentation alleviates IGF-IIR-induced mitochondria dysfunction during heart failure.
    J Mol Cell Cardiol. 2018;122:58-68.
    PubMed     Text format     Abstract available


  10. CHANG SL, Hsiao YW, Tsai YN, Lin SF, et al
    Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure.
    J Mol Cell Cardiol. 2018 Aug 7. pii: S0022-2828(18)30767.
    PubMed     Text format     Abstract available


    July 2018
  11. ERNENS I, Lumley AI, Devaux Y
    Restoration of cardiac function after anaemia-induced heart failure in zebrafish.
    J Mol Cell Cardiol. 2018 Jul 13. pii: S0022-2828(18)30537.
    PubMed     Text format     Abstract available


    April 2018
  12. WANG S, Wu J, You J, Shi H, et al
    HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    J Mol Cell Cardiol. 2018 Apr 4. pii: S0022-2828(18)30089.
    PubMed     Text format     Abstract available


    March 2018
  13. KAIN V, Ingle KA, Kabarowski J, Barnes S, et al
    Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
    J Mol Cell Cardiol. 2018 Mar 8. pii: S0022-2828(18)30067.
    PubMed     Text format     Abstract available


    November 2017
  14. PLUTEANU F, Nikonova Y, Holzapfel A, Herzog B, et al
    Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure.
    J Mol Cell Cardiol. 2017 Nov 27. pii: S0022-2828(17)30355.
    PubMed     Text format     Abstract available


    October 2017
  15. GRANDI E, Dobrev D
    Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?
    J Mol Cell Cardiol. 2017 Oct 25. pii: S0022-2828(17)30334.
    PubMed     Text format     Abstract available


    September 2017
  16. ZHANG R, Shen Y, Zhou L, Sangwung P, et al
    Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.
    J Mol Cell Cardiol. 2017 Sep 4. pii: S0022-2828(17)30303.
    PubMed     Text format     Abstract available


    July 2017
  17. POLZIN A, Piayda K, Keul P, Dannenberg L, et al
    Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
    J Mol Cell Cardiol. 2017 Jul 11. pii: S0022-2828(17)30149.
    PubMed     Text format     Abstract available


    April 2017
  18. WILLIS MS, Holley DW, Wang Z, Chen X, et al
    BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
    J Mol Cell Cardiol. 2017;105:99-109.
    PubMed     Text format     Abstract available


    March 2017
  19. WALWEEL K, Molenaar P, Imtiaz MS, Denniss A, et al
    Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts.
    J Mol Cell Cardiol. 2017;104:53-62.
    PubMed     Text format     Abstract available


    January 2017
  20. ALVARADO FJ, Chen X, Valdivia HH
    Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable.
    J Mol Cell Cardiol. 2017 Jan 5. pii: S0022-2828(17)30001.
    PubMed     Text format     Abstract available


  21. PIQUEREAU J, Moulin M, Zurlo G, Mateo P, et al
    Cobalamin and folate protect mitochondrial and contractile functions in a murine model of cardiac pressure overload.
    J Mol Cell Cardiol. 2017;102:34-44.
    PubMed     Text format     Abstract available


    December 2016
  22. O'CONNELL TD, Block RC, Huang SP, Shearer GC, et al
    omega3-Polyunsaturated Fatty Acids for Heart Failure: Effects of Dose on Efficacy and Novel Signaling through Free Fatty Acid Receptor 4.
    J Mol Cell Cardiol. 2016 Dec 13. pii: S0022-2828(16)30445.
    PubMed     Text format     Abstract available


    March 2016
  23. CAO L, Qin X, Peterson MR, Haller SE, et al
    CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity.
    J Mol Cell Cardiol. 2016;92:185-95.
    PubMed     Text format     Abstract available


  24. STRATTON MS, McKinsey TA
    Epigenetic regulation of cardiac fibrosis.
    J Mol Cell Cardiol. 2016;92:206-13.
    PubMed     Text format     Abstract available


  25. JAMEEL MN, Xiong Q, Mansoor A, Bache RJ, et al
    ATP sensitive K(+) channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart.
    J Mol Cell Cardiol. 2016;92:116-21.
    PubMed     Text format     Abstract available


  26. TRAYNHAM CJ, Hullmann J, Koch WJ
    "Canonical and non-canonical actions of GRK5 in the heart".
    J Mol Cell Cardiol. 2016;92:196-202.
    PubMed     Text format     Abstract available


  27. FU L, Wei CC, Powell PC, Bradley WE, et al
    Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.
    J Mol Cell Cardiol. 2016;92:1-9.
    PubMed     Text format     Abstract available


  28. FELDMAN AM, Gordon J, Wang J, Song J, et al
    BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes.
    J Mol Cell Cardiol. 2016;92:10-20.
    PubMed     Text format     Abstract available


    February 2016
  29. PINEDA-SANABRIA SE, Robertson IM, Sun YB, Irving M, et al
    Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog.
    J Mol Cell Cardiol. 2016 Feb 4. pii: S0022-2828(16)30031.
    PubMed     Text format     Abstract available


  30. VALIENTE-ALANDI I, Schafer AE, Blaxall BC
    Extracellular matrix-mediated cellular communication in the heart.
    J Mol Cell Cardiol. 2016;91:228-37.
    PubMed     Text format     Abstract available


  31. SAMANTA A, Dawn B
    IL-10 for cardiac autophagy modulation: New direction in the pursuit of perfection.
    J Mol Cell Cardiol. 2016;91:204-6.
    PubMed     Text format    


  32. MOORE-MORRIS T, Cattaneo P, Puceat M, Evans SM, et al
    Origins of cardiac fibroblasts.
    J Mol Cell Cardiol. 2016;91:1-5.
    PubMed     Text format     Abstract available


  33. YANO T, Shimoshige S, Miki T, Tanno M, et al
    Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.
    J Mol Cell Cardiol. 2016;91:6-9.
    PubMed     Text format     Abstract available


    December 2015
  34. KUBOTA A, Takano H, Wang H, Hasegawa H, et al
    DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
    J Mol Cell Cardiol. 2015 Dec 28. pii: S0022-2828(15)30165.
    PubMed     Text format     Abstract available


  35. LINDSEY ML, Iyer RP, Jung M, DeLeon-Pennell KY, et al
    Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    J Mol Cell Cardiol. 2015 Dec 22. pii: S0022-2828(15)30155.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: